跳至主要内容
临床试验/NL-OMON51865
NL-OMON51865已完成不适用

3D ultrasound of abdominal aortic aneurysm characteristics for predicting aneurysm shrinkage after endovascular repair - 3D US - EVAR

Rijnstate Ziekenhuis0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 years;
  • Unruptured infrarenal or juxtarenal abdominal aortic aneurysm (AAA);
  • Scheduled for elective endovascular repair (EVAR);
  • Preoperative CTA with iodine contrast scheduled or already made;
  • Informed consent form understood and signed.

排除标准

  • BMI>40 kg/m2;
  • Symptomatic AAA;
  • Implanted pacemaker or ICD;
  • Unable to hold breath for <=7 seconds;
  • Pregnant;
  • Hypersensitivity to the active substance(s) or any of the excipients in
  • Known right-to-left cardiac shunt;
  • Severe pulmonary hypertension (pulmonary artery pressure > 90mmHg);
  • Uncontrolled systemic hypertension;
  • Severe pulmonary disease (e.g. COPD GOLD 3 or 4, adult respiratory distress
  • Clinically unstable cardiac disease (recent, < 3 months, or ongoing
  • myocardial infarction, unstable angina at rest, recent percutaneous coronary
  • intervention, clinically worsening cardiac symptoms, severe cardiac
  • arrhythmia*s, endocarditis, etc.);
  • Prosthetic valves;
  • Loss of renal function (GFR < 31 mL/min), end-stage renal disease;
  • End-stage liver disease;
  • Hypercoagulable status, recent (< 3 months) thrombosis;
  • Congestive heart failure (class III or IV);
  • Psychiatric or other condition that may interfere with the study;
  • Participating in another clinical study that interferes on the primary
  • outcomes of this study;
  • 3D US measurement of AAA is impossible because of bowel gasses or other

研究者

发起方
Rijnstate Ziekenhuis

相似试验

3D ultrasound of abdominal aortic aneurysm... | 临床试验